Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Lexicon Pharmaceutcl (LXRX)

6.78   0.12 (1.8%) 03-07 04:37
Open: 6.72 Pre. Close: 6.66
High: 6.79 Low: 6
Volume: 1,693,583 Market Cap: 959M
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products. The company offers XERMELO, an orally-delivered small molecule drug candidate for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog therapy in adults. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the treatment of type 1 and is in Phase III clinical trials for the treatment of type 2 diabetes; LX9211, which is in Phase I clinical development for the treatment of neuropathic pain; and LX2761 that is in Phase I clinical development for the treatment of diabetes. The company has strategic collaboration and license agreements with Ipsen Pharma SAS; Bristol-Myers Squibb Company; and Genentech, Inc. Lexicon Pharmaceuticals, Inc. was founded in 1995 and is headquartered in The Woodlands, Texas.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 6.793 - 6.834 6.834 - 6.874
Low: 5.913 - 5.956 5.956 - 5.998
Close: 6.705 - 6.777 6.777 - 6.846

Technical analysis

as of: 2021-03-05 5:10:28 PM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 9.64     One year: 11.27
Support: Support1: 6.00    Support2: 4.99
Resistance: Resistance1: 8.26    Resistance2: 9.65
Pivot: 7.47
Moving Average: MA(5): 7.13     MA(20): 7.71
MA(100): 4.18     MA(250): 2.80
MACD: MACD(12,26):     Signal(9): 0.23
Stochastic oscillator: %K(14,3): 23.03     %D(3): 26.83
RSI: RSI(14): 42.65
52-week: High: 9.65  Low: 1.03  Change(%): 206.8
Average Vol(K): 3-Month: 1015353  10-Days: 139499

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
LXRX has closed above bottom band by 4.0%. Bollinger Bands are 23.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 03 Mar 2021
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Given Average Rating of "Hold" by Brokerages - MarketBeat

Sat, 27 Feb 2021
Zacks: Brokerages Anticipate Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Will Announce Quarterly Sales of $170,000.00 - MarketBeat

Fri, 12 Feb 2021
Short Interest in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Declines By 52.9% - MarketBeat

Thu, 14 Jan 2021
Citi lifts Lexicon Pharmaceutical price target to Street high - Seeking Alpha

Thu, 31 Dec 2020
Lexicon Pharmaceuticals Announces Commencement of Dosing in Phase 2 Clinical Study of LX9211 in Post-Herpetic Neuralgia - GlobeNewswire

Wed, 16 Dec 2020
Lexicon Pharmaceuticals Enters Data Collaboration With AC Bioscience - GlobeNewswire

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Outperform Price to Earnings: Outperform
Return on Equity: Outperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 142
Shares Float (M) 44
% Held by Insiders 0.90
% Held by Institutions 91.96
Shares Short (K) 11,380
Shares Short P. Month (K) 12,240

Stock Financials

EPS -0.980
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 0.750
Profit Margin
Operating Margin -655.77
Return on Assets (ttm) -42.8
Return on Equity (ttm) -82.6
Qtrly Rev. Growth -97.7
Gross Profit (p.s.) 1.604
Sales Per Share 0.230
EBITDA (p.s.) -1.494
Qtrly Earnings Growth -63.50
Operating Cash Flow (M) -133
Levered Free Cash Flow (M) 127

Stock Valuations

PE Ratio -6.92
PEG Ratio
Price to Book value 9.04
Price to Sales 29.50
Price to Cash Flow -7.21

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.